119 related articles for article (PubMed ID: 2545766)
1. Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism.
Ambrosi B; Bochicchio D; Ferrario R; Colombo P; Faglia G
J Endocrinol Invest; 1989 Jan; 12(1):31-5. PubMed ID: 2545766
[TBL] [Abstract][Full Text] [Related]
2. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
Bernini GP; Argenio GF; Cerri F; Franchi F
J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
[TBL] [Abstract][Full Text] [Related]
3. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
[TBL] [Abstract][Full Text] [Related]
4. [Cushing's syndrome: diagnostic exploration].
Tabarin A; Roger P
Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
[TBL] [Abstract][Full Text] [Related]
5. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
7. Loperamide test: a simple and highly specific screening test for hypercortisolism in children and adolescents.
Buzi F; Corna A; Pilotta A; Negrini F; Lombardi A; Re T; Ambrosi B
Acta Paediatr; 1997 Nov; 86(11):1177-80. PubMed ID: 9401509
[TBL] [Abstract][Full Text] [Related]
8. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M; Allolio B; Würth G; Winkelmann W
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[TBL] [Abstract][Full Text] [Related]
9. In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
Auernhammer CJ; Riepl RL; Schopohl J; Lehnert P; Müller OA; Stalla GK
Neuroendocrinology; 1994 Jul; 60(1):16-22. PubMed ID: 8090278
[TBL] [Abstract][Full Text] [Related]
10. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
11. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
Streeten DH; Anderson GH; Brennan S; Jones C
J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
[TBL] [Abstract][Full Text] [Related]
12. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
[TBL] [Abstract][Full Text] [Related]
13. Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison's disease.
Ambrosi B; Bochicchio D; Faglia G
Clin Endocrinol (Oxf); 1986 May; 24(5):483-9. PubMed ID: 3024866
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
15. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
Findling JW; Kehoe ME; Shaker JL; Raff H
J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
Lane SJ; Atkinson BA; Swaminathan R; Lee TH
Am J Respir Crit Care Med; 1996 Feb; 153(2):557-60. PubMed ID: 8564097
[TBL] [Abstract][Full Text] [Related]
18. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
Suri D; Weiss RE
J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
[TBL] [Abstract][Full Text] [Related]
19. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
Laudat MH; Cerdas S; Fournier C; Guiban D; Guilhaume B; Luton JP
J Clin Endocrinol Metab; 1988 Feb; 66(2):343-8. PubMed ID: 2828410
[TBL] [Abstract][Full Text] [Related]
20. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
